series-a
Stage
1
Investors
About
Cosomil develops a high-precision diagnostic technology called single-molecule enzyme activity-based liquid biopsy to support early disease diagnosis and pharmaceutical development, focusing notably on early detection of pancreatic cancer.
Explore Cosomil, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.